Pulmonary Services - Diagnostic Testing

Pulmonary Diagnostic Tests are a series of tests which evaluate how well the lungs are performing.  These tests may be performed to help diagnose disease, to monitor disease progression, or therapeutic intervention over time, to evaluate disability, or as a variable in research studies.

The tests are ordered by your physician and may take anywhere from 10 to 90 minutes to perform.  All results are interpreted by a board-certified pulmonologist.  The referring physician should receive the results within approximately two days of the testing.

Contact Us: Appointment Scheduling: (801) 213-2124 Phone: (801) 581-2590 Fax: (801) 585-5350 Hours: 8:00am - 5:00 pm - Monday-Friday Address: 50 North Medical Drive B Level Salt Lake City, UT 84132

Resources Pulmonary Diagnostic Tests Preparing For Your Visit Performance Evaluations

Richard E. Kanner, M.D.

Locations

University Hospital

(801) 581-7806

Specialties: Advanced Lung Disease, General Pulmonary, Pulmonary, Pulmonary Function, Pulmonary Rehabilitation

Clinical Trials

• RAINER

Related Documents

Diseases and Conditions

• Cystic Fibrosis

Pediatric Diseases and Conditions

• Cystic Fibrosis and the Digestive System
• Cystic Fibrosis and the Reproductive System
• Cystic Fibrosis and the Respiratory System
• Cystic Fibrosis in Children
• Diagnosis of Cystic Fibrosis
• Feeding Your Child with Cystic Fibrosis
• Symptoms of Cystic Fibrosis
• The Genetics of Cystic Fibrosis
• Treatment for Cystic Fibrosis
• Autosomal Recessive: Cystic Fibrosis, Sickle Cell Anemia, Tay Sachs Disease
• Chronic Respiratory Disorders
• Cystic Fibrosis Overview

Interactive Tools

• Cystic Fibrosis Quiz

News

• Study: Cystic Fibrosis Patients Struggle to Exercise
• Differences Seen in Lung Microbes of Cystic Fibrosis Patients
• Drug-Resistant 'Superbug' May Spread Among Patients, Study Finds
• Human Airways' 'Brush' Mechanism Gives Clues to Lung Diseases
• Inhaler Approved for Cystic Fibrosis Patients
• Preemies' Increased Survival Comes With No Rise in Disabilities: Study

Drug Reference

• Dornase Alfa
• Acetylcysteine
• Pancreatin
• Pancrelipase
• Tobramycin